| |
| |
|
| Insider
Information: |
George Jean |
| Relationship: |
Director |
| City: |
Lexington |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
25,063 |
|
|
Indirect Shares
|
9,489,849 |
|
|
| Direct
Value |
$959,184 |
|
|
|
Indirect Value
|
$158,428,482 |
|
|
| Total
Shares |
9,514,912 |
|
|
| Total
Value |
$159,387,667 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Portola Pharmaceuticals Inc |
PTLA |
Director |
2013-05-28 |
0 |
2013-05-28 |
8,632 |
Premium* |
|
|
Acceleron Pharma Inc |
XLRN |
Director |
2020-01-22 |
5,127 |
2019-06-28 |
0 |
Premium* |
|
|
Zeltiq Aesthetics Inc |
ZLTQ |
Director |
2015-07-22 |
5,786 |
2014-07-31 |
0 |
Premium* |
|
|
Calithera Biosciences, Inc. |
CALA |
Director, 10% Owner |
2014-10-07 |
0 |
2014-10-07 |
2,110,082 |
Premium* |
|
|
Astria Therapeutics, Inc |
ATXS |
Director |
2015-06-30 |
0 |
2015-06-30 |
90,764 |
Premium* |
|
|
Disc Medicine, Inc |
IRON |
Director, 10% Owner |
|
0 |
2021-02-05 |
4,836,106 |
Premium* |
|
|
Cyteir Therapeutics, Inc. |
CYT |
Director |
2024-02-14 |
14,150 |
2024-02-14 |
2,444,265 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
46 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PTLA |
Portola Pharmaceuticals I... |
Director |
– • – |
2013-05-28 |
4 |
A |
$0.00 |
$0 |
I/I |
1,543,280 |
8,632 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
Director |
– • – |
2013-09-24 |
4 |
A |
$0.00 |
$0 |
I/I |
223,806 |
2,449,764 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
Director |
– • – |
2013-09-24 |
4 |
A |
$0.00 |
$0 |
I/I |
2,280,245 |
2,513,783 |
0 |
- |
|
| ZLTQ |
Zeltiq Aesthetics Inc |
Former 10% Owner |
– • – |
2014-01-17 |
4 |
A |
$0.00 |
$0 |
I/I |
19,893 |
19,893 |
0 |
- |
|
| CALA |
Calithera Biosciences, In... |
Director |
– • • |
2014-10-07 |
4 |
A |
$0.00 |
$0 |
I/I |
1,810,082 |
1,810,082 |
0 |
- |
|
| ZLTQ |
Zeltiq Aesthetics Inc |
Director |
– • – |
2015-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
4,996 |
4,996 |
0 |
- |
|
| ATXS |
Astria Therapeutics, Inc |
Director |
– • – |
2015-06-30 |
4 |
A |
$0.00 |
$0 |
I/I |
1,632,076 |
78,342 |
0 |
- |
|
| ZLTQ |
Zeltiq Aesthetics Inc |
Director |
– • – |
2015-07-22 |
4 |
A |
$0.00 |
$0 |
D/D |
790 |
5,786 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
Director |
– • – |
2017-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
1,250 |
1,250 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
Director |
– • – |
2018-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,250 |
2,500 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
Director |
– • – |
2019-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
1,250 |
3,750 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
Director |
– • – |
2019-06-26 |
4 |
A |
$0.00 |
$0 |
I/I |
11,812 |
11,812 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
Director |
– • – |
2020-01-22 |
4 |
A |
$0.00 |
$0 |
D/D |
1,377 |
5,127 |
0 |
- |
|
| CYT |
Cyteir Therapeutics, Inc. |
Director |
– • – |
2021-06-22 |
4 |
A |
$0.00 |
$0 |
I/I |
2,444,268 |
2,444,268 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
Director |
– • – |
2014-06-20 |
4 |
AS |
$35.02 |
$51,024 |
I/I |
(1,457) |
1,937,574 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
Director |
– • – |
2014-06-23 |
4 |
AS |
$35.27 |
$480,307 |
I/I |
(13,618) |
1,923,956 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
Director |
– • – |
2014-06-24 |
4 |
AS |
$35.03 |
$364,382 |
I/I |
(10,402) |
1,913,554 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
Director |
– • – |
2014-06-25 |
4 |
AS |
$35.00 |
$5,985 |
I/I |
(171) |
1,913,383 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
Director |
– • – |
2014-06-26 |
4 |
AS |
$35.01 |
$361,303 |
I/I |
(10,320) |
1,903,063 |
0 |
- |
|
| ZLTQ |
Zeltiq Aesthetics Inc |
Director |
– • – |
2014-11-03 |
4 |
AS |
$25.15 |
$439,629 |
D/D |
(17,483) |
0 |
0 |
- |
|
| ZLTQ |
Zeltiq Aesthetics Inc |
Director |
– • – |
2015-01-15 |
4 |
AS |
$29.26 |
$511,490 |
D/D |
(17,483) |
0 |
0 |
- |
|
| CALA |
Calithera Biosciences, In... |
Director |
– • • |
2014-10-07 |
4 |
B |
$10.00 |
$3,000,000 |
I/I |
300,000 |
2,110,082 |
2.25 |
- |
|
| ATXS |
Astria Therapeutics, Inc |
Director |
– • – |
2015-06-30 |
4 |
B |
$12.00 |
$3,105,312 |
I/I |
258,776 |
90,764 |
2.1 |
- |
|
| ZLTQ |
Zeltiq Aesthetics Inc |
Former 10% Owner |
– • – |
2014-01-17 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,988,813) |
33,969 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
Director |
– • – |
2016-12-07 |
4 |
D |
$33.98 |
$747,560 |
I/I |
(22,000) |
105,122 |
0 |
- |
|
46 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
